Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Der Pathologe|June 18, 2011
[Ectomesenchymal chondromyxoid tumor of the anterior tongue]S Muenst, J Jakscha, G Jundt, et al.Disease Markers|September 10, 2010
Diagnostic and prognostic utility of PD-1 in B cell lymphomasS Muenst, S Hoeller, N Willi, et al.Journal of Internal Medicine|January 11, 2016
The immune system and cancer evasion strategies: therapeutic conceptsS Muenst, H Läubli, S D Soysal, et al.Der Pathologe|May 5, 2012
[Embolization of hydrophilic guide wire coating]S Muenst, N Willi, G Cathomas, et al.Breast Cancer Research and Treatment|June 13, 2013
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancerS Muenst, S D Soysal, F Gao, et al.Breast Cancer Research and Treatment|December 18, 2012
PTP1B expression is an independent positive prognostic factor in human breast cancerS Soysal, E C Obermann, F Gao, et al.British Journal of Cancer|March 23, 2013
EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancerS D Soysal, S Muenst, T Barbie, et al.Disease Markers|November 6, 2013
Nuclear expression of snail is an independent negative prognostic factor in human breast cancerS Muenst, S Däster, E C Obermann, et al.Breast Cancer Research and Treatment|May 21, 2014
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancerS Muenst, A R Schaerli, F Gao, et al.Breast Cancer Research and Treatment|September 13, 2014
Identification and translational validation of novel mammaglobin-A CD8 T cell epitopesS D Soysal, S Muenst, J Kan-Mitchell, et al.Pageof 1